Log in to save to my catalogue

Review of Current Human Genome-Scale Metabolic Models for Brain Cancer and Neurodegenerative Disease...

Review of Current Human Genome-Scale Metabolic Models for Brain Cancer and Neurodegenerative Disease...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a832935e117749fea6cbbd17e92b7f65

Review of Current Human Genome-Scale Metabolic Models for Brain Cancer and Neurodegenerative Diseases

About this item

Full title

Review of Current Human Genome-Scale Metabolic Models for Brain Cancer and Neurodegenerative Diseases

Publisher

Switzerland: MDPI AG

Journal title

Cells (Basel, Switzerland), 2022-08, Vol.11 (16), p.2486

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Brain disorders represent 32% of the global disease burden, with 169 million Europeans affected. Constraint-based metabolic modelling and other approaches have been applied to predict new treatments for these and other diseases. Many recent studies focused on enhancing, among others, drug predictions by generating generic metabolic models of brain...

Alternative Titles

Full title

Review of Current Human Genome-Scale Metabolic Models for Brain Cancer and Neurodegenerative Diseases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a832935e117749fea6cbbd17e92b7f65

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a832935e117749fea6cbbd17e92b7f65

Other Identifiers

ISSN

2073-4409

E-ISSN

2073-4409

DOI

10.3390/cells11162486

How to access this item